MedTrace Logo

Cytokine Response in Septic Shock

NCT01770457 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 325

Last updated 2013-07-25

No results posted yet for this study

Summary

This study is designed to examine the early sequential cytokine responses during antibiotic therapy and resuscitation of septic shock in relation to clinical manifestations of disease.

The specific objective is to obtain sequential serum samples from patients with septic shock, examine a broad range of cytokine responses (TNF, IL-1, IL-6, MIF, LIF, HMGB1, etc) in a rigorous manner and correlate these responses to administration of antibiotics, resuscitative efforts and physiologic responses to illness (temp, HR, blood pressure, WBC, etc).

Conditions

  • Septic Shock

Sponsors & Collaborators

  • University of Manitoba

    lead OTHER

Principal Investigators

  • Anand Kumar, MD · University of Manitoba

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2014-02-28
Completion
2014-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01770457 on ClinicalTrials.gov